跳至主要内容
CAS 1 条记录

CAS 1303-00-0

CAS 1303-00-0 与法规 1223/2009 附件 II–VI 中的 1 条欧盟附件记录相匹配。

CAS 1303-00-0 的记录

1 共

化学身份与性质

CAS 1303-00-0 的 PubChem 二维化学结构
CAS 1303-00-0PubChem CID 14770

Gallium arsenide

Gallium Arsenide can cause cancer according to California Labor Code. — California Office of Environmental Health Hazard Assessment (OEHHA)

IUPAC 名称
gallanylidynearsane
分子式
AsGa
分子量
144.645 g/mol
精确质量
143.84717 Da
拓扑极性表面积
0.0 Ų
氢键供体
0
氢键受体
0
共价单元
1
已定义的立体中心
0

又称

Gallium arsenide (GaAs)Gallium monoarsenideGallium monoarsenide (GaAs)GaAs27FC46GA44Gallium ArsenatumRefChem:58150215-114-8
另有 15 个已报告名称
CCRIS 4020HSDB 4376EINECS 215-114-8arsinogallaneUNII-27FC46GA44GalliummonoarsenideGallium Arsenide, piecesEC 215-114-8GALLIUM ARSENIDE [MI]Gallium arsenide, pieces, 99.999% trace metals basisGallium arsenide Optical Window, 12.7mm (0.5in) dia x 1mm (0.04in) thickGallium arsenide Optical Window, 12.7mm (0.5in) dia x 2mm (0.08in) thickGallium arsenide Optical Window, 25.4mm (1.0in) dia x 2mm (0.08in) thickGallium arsenide Optical Window, 50.8mm (2.0in) dia x 2mm (0.08in) thickGallium arsenide, (single crystal substrate), <100>, diam. x thickness 2 in. x 0.5 mm

来自其他科学数据库的证据

NIH PubChem PUG-View
标识符精确匹配14770

Attributed physical-property, hazard, environmental and use annotations.

  • Substance: Gallium Arsenide 来源: NTP Technical Reports
  • NTP Technical Report: TR-492: Toxicology and Carcinogenesis Studies of Gallium Arsenide (CASRN 1303-00-0) in F344/N Rats and B6C3F1 Mice (Inhalation Studies) (2000 ) 来源: NTP Technical Reports
  • Peer Review Date: 05/21/99 来源: NTP Technical Reports
  • Conclusion for Male Rat: No Evidence 来源: NTP Technical Reports
  • Conclusion for Female Rat: Clear Evidence 来源: NTP Technical Reports
  • Conclusion for Male Mice: No Evidence 来源: NTP Technical Reports
  • Conclusion for Female Mice: No Evidence 来源: NTP Technical Reports
  • Summary: Under the conditions of these 2-year inhalation studies, there was no evidence of carcinogenic activity of gallium arsenide in male F344/N rats exposed to 0.01, 0.1, or 1.0 mg/m3. There was clear evidence of carcinogenic activity in female F344/N rats based on increased incidences of benign and malignant neoplasms in the lung. Increased incidences of benign neoplasms of the adrenal medulla and increased incidences of mononuclear cell leukemia were also considered to be exposure related. There was no evidence of carcinogenic activity in male or female B6C3F1 mice exposed to 0.1, 0.5, or 1.0 mg/m3.; Exposure to gallium arsenide caused a spectrum of nonneoplastic lesions in the lung of rats and mice, the larynx of male rats and hyperplasia of the tracheobronchial lymph node in mice. 来源: NTP Technical Reports
  • Carcinogen Classification: 1, carcinogenic to humans. (L135) 来源: Toxin and Toxin Target Database (T3DB)
  • First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. IMMEDIATELY call a physician and be prepared to transport the victim to a hospital even if no symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Ap 来源: CAMEO Chemicals
  • Signal: Danger 来源: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • GHS Hazard Statements: H350: May cause cancer [Danger Carcinogenicity]; H360F: May damage fertility [Danger Reproductive toxicity]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] 来源: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Precautionary Statement Codes: P203, P260, P264, P270, P280, P318, P319, P405, and P501 (click each P-code to see the statement) 来源: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Note: This chemical does not meet GHS hazard criteria for 6.2% (7 of 112) of reports. 来源: European Chemicals Agency (ECHA)
  • Signal: Danger 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H350 (88.4%): May cause cancer [Danger Carcinogenicity]; H360 (50.9%): May damage fertility or the unborn child [Danger Reproductive toxicity]; H372 (88.4%): Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] 来源: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P203, P260, P264, P270, P280, P318, P319, P405, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 112 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 7 of 112 reports by companies.; There are 6 notifications provided by 105 of 112 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • Signal: Danger 来源: NITE-CMC
  • GHS Hazard Statements: H350: May cause cancer [Danger Carcinogenicity]; H360: May damage fertility or the unborn child [Danger Reproductive toxicity]; H370: Causes damage to organs [Danger Specific target organ toxicity, single exposure]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] 来源: NITE-CMC
  • Precautionary Statement Codes: P203, P260, P264, P270, P280, P308+P316, P318, P319, P321, P405, and P501 (click each P-code to see the statement) 来源: NITE-CMC
  • Signal: Danger 来源: Hazardous Chemical Information System (HCIS), Safe Work Australia
  • Health Effects: Arsenic poisoning can lead to death from multi-system organ failure, probably from necrotic cell death, not apoptosis. Arsenic is also a known carcinogen, esepcially in skin, liver, bladder and lung cancers. (T1, L20) 来源: Toxin and Toxin Target Database (T3DB)
  • Toxicity Summary: Arsenic and its metabolites disrupt ATP production through several mechanisms. At the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. Hydrogen peroxide production is also increased, which might form reactive oxygen species and oxidative stress. Arsenic's carginogenicity is influenced by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. The binding of other arsenic protein targets may also cause altered DNA repair enzyme activity, altered DNA methylation patterns and cell proliferation. (T1, A17) 来源: Toxin and Toxin Target Database (T3DB)

映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录

科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。

其他来源的覆盖范围和匹配状态
来源结果已检查
NIH PubChem PUG-View精确匹配2026-08-31

已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

本站如何使用 CAS 1303-00-0

CAS 1303-00-0 是化学文摘社 (Chemical Abstracts Service) 的标识符,用于将本页对应到特定物质。在当前数据集中,有 1 条欧盟附件记录共用该标识符,可帮助您交叉核对同一物质是出现在一种还是多种监管情境中。

当供应商规格书、SDS 或原料档案给出 CAS 1303-00-0,而您需要在一处查看所有关联的附件 II–VI 记录时,请使用本页。上方的条目卡片是查看浓度限值、警示语、附件归属和产品类型条件的最快途径。

常见问题

以 CAS 1303-00-0 标识的物质,如果在不同情境下适用不同条件,可能出现在欧盟化妆品法规的多个附件中。例如,某物质可能在附件 III 中按特定条件受到限制,同一 CAS 也可能在附件 IV 中作为准用着色剂按另行规定的条件出现。每个条目都必须单独审查。

将 CAS 编号与您的原料规格书和 CoA 文件进行交叉核对。当该 CAS 出现在附件 II 时,应核实其不存在。当其出现在附件 III 时,应核实您的配方满足浓度限值和产品类型条件。共用此 CAS 编号的所有附件条目均列于上方。

CAS 编号由美国化学文摘社 (Chemical Abstracts Service) 分配,全球通用。EC 编号是来自 EINECS、ELINCS 或 NLP 清单等名录的欧盟委员会标识符。两种标识符都可能出现在欧盟化妆品附件条目中。有些物质两者都有,有些只有其一,一些较旧的条目可能两者都没有。

INCI 检查器接受成分名称、CAS 编号和 EC 编号。可直接检查此 CAS 编号,然后对照供应商规格书和所有关联的附件条件核实结果。

工具与后续步骤

检查您的配方

扫描完整的 INCI 成分表,然后使用 CAS 1303-00-0 交叉核对匹配物质背后的任何供应商文件。

INCI 检查器

浏览附件

按类别浏览所有欧盟化妆品法规附件。

全部附件

按名称搜索

搜索您的文件中与 CAS 1303-00-0 并列出现的 INCI 名称、别名或相关标识符。

搜索